Curing Hepatitis C virus infection: Best practices from the U.S. Department of Veterans Affairs

Annals of Internal Medicine

Volumn 167, Issue 7, 2017, Pages 499-504

  Belperio, Pamela S ^a   Chartier, Maggie ^b   Ross, David B ^c   Alaigh, Poonam ^c   Shulkin, David ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE MANAGER; CLINICAL PHARMACY; CLINICAL PRACTICE; COMORBIDITY; DRUG DEPENDENCE; ELECTRONIC MEDICAL RECORD; FEMALE; FUNDING; HEPATITIS C; HUMAN; INTERSECTORAL COLLABORATION; INVESTMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL DISEASE; NURSE PRACTITIONER; PATIENT CARE; PHYSICIAN ASSISTANT; POINT OF CARE TESTING; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SOCIAL WORKER; SUBSTANCE USE; SUSTAINED VIROLOGIC RESPONSE; TELECONFERENCE; VETERAN; VIDEORECORDING; ECONOMICS; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE DELIVERY; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; TELEMEDICINE; UNITED STATES; VETERANS HEALTH;

ANTIVIRUS AGENT;

ANTIVIRAL AGENTS; COMORBIDITY; DELIVERY OF HEALTH CARE; FEMALE; FINANCING, GOVERNMENT; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; TELEMEDICINE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; VETERANS HEALTH;

EID: 85030455605     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-1073     Document Type: Article

References (29)

1. National Academies of Sciences, Engineering, and Medicine. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report Phase Two ReportPhase Two Report. Washington, DC: National Academies Pr; 2017. [PMID: 28737845] doi:10.17226/24731
2. Buckley GJ, Strom BL. A national strategy for the elimination of viral hepatitis emphasizes prevention, screening, and universal treatment of hepatitis C. Ann Intern Med. 2017;166:895-6. [PMID: 28384754] doi:10.7326/M17-0766
3. Beste LA, Ioannou GN. Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs. Epidemiol Rev. 2015;37:131-43. [PMID: 25600415] doi:10.1093/epirev /mxu002
4. Surface Transportation and Veterans Health Care Choice Improvement Act of 2015, H.R. 3236, 114th Cong. (2015-2016).
5. U.S. Department of Veterans Affairs. Viral Hepatitis. Updated 20 July 2017. Accessed at www.hepatitis.va.gov on 20 April 2017.
6. Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA. Realworld effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients. Antivir Ther. 2016. [PMID: 27934775] doi:10.3851/IMP3117
7. Ioannou GN, Beste LA, Chang MF, Green PK, Lowy E, Tsui JI, et al. Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the Veterans Affairs national health care system. Gastroenterology. 2016;151:457-71. [PMID: 27267053] doi: 10.1053/j.gastro.2016.05.049
8. Maier MM, Ross DB, Chartier M, Belperio PS, Backus LI. Cascade of care for hepatitis C virus infection within the US Veterans Health Administration. Am J Public Health. 2016;106:353-8. [PMID: 26562129] doi:10.2105/AJPH.2015.302927
9. Backus LI, Gavrilov S, Loomis TP, Halloran JP, Phillips BR, Belperio PS, et al. Clinical case registries: simultaneous local and national disease registries for population quality management. J Am Med Inform Assoc. 2009;16:775-83. [PMID: 19717794] doi:10.1197/jamia .M3203
10. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al; Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1-32. [PMID: 22895429]
11. Moyer VA; U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:349-57. [PMID: 23798026] doi:10.7326/0003-4819-159-5-201309030 -00672
12. Backus LI, Belperio PS, Loomis TP, Mole LA. Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care. Am J Public Health. 2014;104 Suppl 4:S555-61. [PMID: 25100421] doi:10.2105/AJPH .2014.302090
13. Noska AJ, Belperio PS, Loomis TP, O'Toole TP, Backus LI. Engagement in the hepatitis C care cascade among homeless veterans, 2015. Public Health Rep. 2017;132:136-9. [PMID: 28135425] doi:10 .1177/0033354916689610
14. Jonas MC, Rodriguez CV, Redd J, Sloane DA, Winston BJ, Loftus BC. Streamlining screening to treatment: the hepatitis C cascade of care at Kaiser Permanente Mid-Atlantic states. Clin Infect Dis. 2016; 62:1290-6. [PMID: 26908812] doi:10.1093/cid/ciw086
15. Ross DB, Gonzalez R, Morgan T, Park A. Best practices in screening, diagnosis, and treatment along the Veteran Health Administration's cascade of HCV care. In: Addressing the Unique Needs of Military Veterans With Chronic HCV Infection. Federal Practitioner Supplement. 1 February 2017.
16. Toussaint JS, Berry LL. The promise of Lean in health care. Mayo Clin Proc. 2013;88:74-82. [PMID: 23274021] doi:10.1016/j.mayocp .2012.07.025
17. Rogal SS, Yakovchenko V, Waltz TJ, Powell BJ, Kirchner JE, Proctor EK, et al. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample. Implement Sci. 2017;12:60. [PMID: 28494811] doi:10.1186/s13012-017-0588-6
18. Arora S, Kalishman S, Thornton K, Dion D, Murata G, Deming P, et al. Expanding access to hepatitis C virus treatment - Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010;52:1124-33. [PMID: 20607688] doi:10.1002/hep.23802
19. Beste LA, Glorioso TJ, Ho PM, Au DH, Kirsh SR, Todd-Stenberg J, et al. Telemedicine specialty support promotes hepatitis C treatment by primary care providers in the Department of Veterans Affairs. Am J Med. 2017;130:432-8. [PMID: 27998682] doi:10.1016/j.amjmed .2016.11.019
20. Rongey C, Shen H, Hamilton N, Backus LI, Asch SM, Knight S. Impact of rural residence and health system structure on quality of liver care. PLoS One. 2013;8:e84826. [PMID: 24386420] doi:10 .1371/journal.pone.0084826
21. Backus LI, Belperio PS, Shahoumian TA, Mole LA. Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens. J Clin Gastroenterol. 2015;49:329-35. [PMID: 24667591] doi:10.1097/MCG.0000000000000124
22. Ourth H, Groppi J, Morreale AP, Quicci-Roberts K. Clinical pharmacist prescribing activities in the Veterans Health Administration. Am J Health Syst Pharm. 2016;73:1406-15. [PMID: 27605319] doi:10 .2146/ajhp150778
23. Tsui JI, Williams EC, Green PK, Berry K, Su F, Ioannou GN. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Drug Alcohol Depend. 2016;169: 101-9. [PMID: 27810652] doi:10.1016/j.drugalcdep.2016.10.021
24. U.S. Department of Veterans Affairs. VA expands hepatitis C drug treatment [press release]. Washington, DC: U.S. Department of Veterans Affairs; 9 March 2016. Accessed at www.va.gov/opa /pressrel/pressrelease.cfm?id=2762 on 10 April 2017.
25. Bhattacharya D, Belperio PS, Shahoumian TA, Loomis TP, Goetz MB, Mole LA, et al. Effectiveness of all-oral antiviral regimens in 996 human immunodeficiency virus/hepatitis C virus genotype 1-coinfected patients treated in routine practice. Clin Infect Dis. 2017;64:1711-20. [PMID: 28199525] doi:10.1093/cid/cix111
26. El-Serag HB, Kramer J, Duan Z, Kanwal F. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat. 2016;23:687-96. [PMID: 27040447] doi:10.1111/jvh.12533
27. Yehia BR, Schranz AJ, Umscheid CA, Lo Re V 3rd. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One. 2014;9:e101554. [PMID: 24988388] doi:10.1371/journal.pone.0101554
28. Spradling PR, Rupp L, Moorman AC, Lu M, Teshale EH, Gordon SC, et al; Chronic Hepatitis Cohort Study Investigators. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis. 2012;55:1047-55. [PMID: 22875876]
29. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med. 2013;368:1859-61. [PMID: 23675657] doi:10.1056/NEJMp1302973